Investigation of 2-substituted-5-methylsulfonylbenzoxazole derivatives as potential cholinesterase inhibitors: Synthesis, in vitro, and computational studies

ArticleAçık Erişim

Özet

In this study, a new series of 2-substituted-5-methylsulfonylbenzoxazole derivatives (C1-C16) were successfully synthesized. The structures of the compounds were confirmed by FT-IR, 1H NMR, 13C NMR, and mass spectroscopy, and the results for acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzyme inhibitory activity were reported as IC₅₀ and Ki values. The compounds' Ki values against AChE ranged from 7.55 ± 2.88 to 87.39 ± 11.67 nM, and their Ki values against BChE ranged from 3.23 ± 0.64 to 107.86 ± 13.38 nM. Accordingly, all compounds except C1, C2, C11, and C12 were found to be more effective than donepezil against AChE, and all compounds except C1, C5, and C12 were found to be more effective than donepezil against BChE. Molecular docking studies were performed for all compounds against the AChE and BChE enzymes. Conventional hydrogen bonds and π interactions (π-π stacked, π-π T-shaped, π-alkyl, π-sigma, π-cation) were observed in the interactions of the compounds with the target enzymes. Molecular dynamics (MD) simulation of complexes formed by compounds with the highest inhibition activity on the two enzymes affirmed formation of stable complexes. Additionally, the molecular electrostatic potential (MEP) map of all compounds and the extent to which the HOMO-LUMO energy gaps affect the reactivity, stability, and inhibitor profiles of these compounds were investigated using density functional theory (DFT) studies, a computational analysis method. The study proves that 2-substituted-5-methylsulfonylbenzoxazole derivatives exhibit potent and selective cholinesterase inhibition. © 2025 Elsevier Inc.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/10772Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorCihan, Cansu
dc.contributor.authorFaydali, Nagihan
dc.contributor.authorErol, Meryem
dc.contributor.authorArpaci, Özlem Temiz
dc.contributor.authorMuhammed, Muhammed Tilahun
dc.contributor.authorDilek, Esra
dc.date.accessioned2026-10-18T20:25:54.911720401Z
dc.date.available2026-10-18T20:25:54.911720401Z
dc.date.issued2025
dc.description.abstractIn this study, a new series of 2-substituted-5-methylsulfonylbenzoxazole derivatives (C1-C16) were successfully synthesized. The structures of the compounds were confirmed by FT-IR, 1H NMR, 13C NMR, and mass spectroscopy, and the results for acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzyme inhibitory activity were reported as IC₅₀ and Ki values. The compounds' Ki values against AChE ranged from 7.55 ± 2.88 to 87.39 ± 11.67 nM, and their Ki values against BChE ranged from 3.23 ± 0.64 to 107.86 ± 13.38 nM. Accordingly, all compounds except C1, C2, C11, and C12 were found to be more effective than donepezil against AChE, and all compounds except C1, C5, and C12 were found to be more effective than donepezil against BChE. Molecular docking studies were performed for all compounds against the AChE and BChE enzymes. Conventional hydrogen bonds and π interactions (π-π stacked, π-π T-shaped, π-alkyl, π-sigma, π-cation) were observed in the interactions of the compounds with the target enzymes. Molecular dynamics (MD) simulation of complexes formed by compounds with the highest inhibition activity on the two enzymes affirmed formation of stable complexes. Additionally, the molecular electrostatic potential (MEP) map of all compounds and the extent to which the HOMO-LUMO energy gaps affect the reactivity, stability, and inhibitor profiles of these compounds were investigated using density functional theory (DFT) studies, a computational analysis method. The study proves that 2-substituted-5-methylsulfonylbenzoxazole derivatives exhibit potent and selective cholinesterase inhibition. © 2025 Elsevier Inc.
dc.description.sponsorshipWe thank Prof. Dr. Hakan Goker from the Central Laboratory of Ankara University Faculty of Pharmacy, Ankara University, for NMR and Mass analyses.
dc.identifier.doi10.1016/j.bioorg.2025.109281
dc.identifier.eissn1090-2120
dc.identifier.issn0045-2068
dc.identifier.pmid41297217
dc.identifier.scopus2-s2.0-105022887539
dc.identifier.startpage109281
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/10772
dc.identifier.volume167
dc.identifier.wosWOS:001630904700001
dc.language.isoen
dc.publisherAcademic Press Inc.
dc.relation.ispartofBioorganic Chemistry
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectADMET
dc.subjectBenzoxazole
dc.subjectCholinesterase
dc.subjectDFT
dc.subjectMD simulation
dc.subjectMolecular docking
dc.subjectAcetylcholinesterase
dc.subjectAnimals
dc.subjectBenzoxazoles
dc.subjectButyrylcholinesterase
dc.subjectCholinesterase Inhibitors
dc.subjectDose-Response Relationship, Drug
dc.subjectHumans
dc.subjectMolecular Docking Simulation
dc.subjectMolecular Structure
dc.subjectStructure-Activity Relationship
dc.subject2 (4 benzylphenyl) 5 methylsulfonylbenzoxazole
dc.subject2 (4 fluorophenyl) 5 methylsulfonylbenzoxazole
dc.subject2 (4 phenyl) 5 methylsulfonylbenzoxazole
dc.subject2 (phenyl 4 sulfonamide) 5 methylsulfonylbenzoxazole
dc.subject5 methylsulfonylbenzoxazole derivative
dc.subjectbenzoxazole derivative
dc.subjectcarbon 11
dc.subjectcholinesterase inhibitor
dc.subjectdonepezil
dc.subjectligand
dc.subjectunclassified drug
dc.subjectAlzheimer disease
dc.subjectArticle
dc.subjectcarbon nuclear magnetic resonance
dc.titleInvestigation of 2-substituted-5-methylsulfonylbenzoxazole derivatives as potential cholinesterase inhibitors: Synthesis, in vitro, and computational studies
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus6
rdl.citation.wos6
rdl.departmentDepartment of Biochemistry, Faculty of Pharmacy, Erzincan Binali Yıldırım University, Erzincan, 24002, Turkey.
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)
rdl.wos.indexIndex Chemicus (IC)